Harte Group

Shilpa Pharma Inc is a pharmaceutical company based in Doylestown, PA, specializing in the development and manufacturing of active pharmaceutical ingredients and formulations. With a strong focus on research and development, they offer a wide range of services including chemical development, process development, and custom peptide synthesis. Committed to quality and innovation, Shilpa Pharma Inc strives to provide effective and safe pharmaceutical solutions. Operating globally, Shilpa Pharma Inc has multiple manufacturing units and research centers in India, including Raichur, Jadcherla, and Hyderabad. With a dedicated team of professionals and state-of-the-art facilities, they are able to deliver high-quality products and services to meet the needs of the pharmaceutical industry. With a strong emphasis on sustainability and corporate social responsibility, Shilpa Pharma Inc is dedicated to making a positive impact on the healthcare sector.Generated from the website

Aprea Therapeutics, Inc is a biopharmaceutical company based in Doylestown, PA that is dedicated to revolutionizing cancer treatment through their pioneering approach to synthetic lethality and precision oncology. With a diversified portfolio of clinical and pre-clinical assets, Aprea Therapeutics develops highly selective DDR-targeted therapeutics that aim to address the unmet medical needs of cancer patients with mutations in DNA damage response genes, while maximizing efficacy and minimizing toxicity.Generated from the website

ICON is a global company that offers a comprehensive range of solutions for product development and commercialization in various industries, including biotech, government and public health, medical device, and pharmaceuticals. Their services cover the entire lifecycle of a product, from early clinical trials to real-world intelligence and strategic solutions. With a focus on therapeutic areas such as cardiovascular, central nervous system, oncology, and women's health, ICON provides expertise and insights to drive effective outcomes and achieve regulatory authorization. They are known for their thought leadership and contributions to industry publications, as well as their commitment to diversity and inclusion in clinical trials. ICON's mission is to help clients accelerate the development of life-saving drugs and devices while improving the quality of life for patients.Generated from the website